Shariat, S., Badiee, A., Jalali, S., Mansourian, M., Yazdani, M., Mortazavi, S., & Jaafari, M. (2014). P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer. Cancer Letters, 355(1), 54-60. https://doi.org/10.1016/j.canlet.2014.09.016 (Original work published 2014)